The DOI matches its Crossref record; 78 of the 79 references it cites were found in a registry or an index.
Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis
Open accessPublished version of a preprint
Abstract
BACKGROUND: Circulating lipoprotein lipids cause coronary heart disease (CHD). However, the precise way in which one or more lipoprotein lipid-related entities account for this relationship remains unclear. Using genetic instruments for lipoprotein lipid traits implemented through multivariable Mendelian randomisation (MR), we sought to compare their causal roles in the aetiology of CHD. METHODS AND FINDINGS: We conducted a genome-wide association study (GWAS) of circulating non-fasted lipoprotein lipid traits in the UK Biobank (UKBB) for low-density lipoprotein (LDL) cholesterol, triglycerides, and apolipoprotein B to identify lipid-associated single nucleotide polymorphisms (SNPs). Using data from CARDIoGRAMplusC4D for CHD (consisting of 60,801 cases and 123,504 controls), we performed univariable and multivariable MR analyses. Similar GWAS and MR analyses were conducted for high-density lipoprotein (HDL) cholesterol and apolipoprotein A-I. The GWAS of lipids and apolipoproteins in the UKBB included between 393,193 and 441,016 individuals in whom the mean age was 56.9 y (range 39-73 y) and of whom 54.2% were women. The mean (standard deviation) lipid concentrations were LDL cholesterol 3.57 (0.87) mmol/L and HDL cholesterol 1.45 (0.38) mmol/L, and the median triglycerides was 1.50 (IQR = 1.11) mmol/L. The mean (standard deviation) values for apolipoproteins B and A-I were 1.03 (0.24) g/L and 1.54 (0.27) g/L, respectively. The GWAS identified multiple independent SNPs associated at P < 5 × 10-8 for LDL cholesterol (220), apolipoprotein B (n = 255), triglycerides (440), HDL cholesterol (534), and apolipoprotein A-I (440). Between 56%-93% of SNPs identified for each lipid trait had not been previously reported in large-scale GWASs. Almost half (46%) of these SNPs were associated at P < 5 × 10-8 with more than one lipid-related trait. Assessed individually using MR, LDL cholesterol (odds ratio [OR] 1.66 per 1-standard-deviation-higher trait; 95% CI: 1.49-1.86; P < 0.001), triglycerides (OR 1.34; 95% CI: 1.25-1.44; P < 0.001) and apolipoprotein B (OR 1.73; 95% CI: 1.56-1.91; P < 0.001) had effect estimates consistent with a higher risk of CHD. In multivariable MR, only apolipoprotein B (OR 1.92; 95% CI: 1.31-2.81; P < 0.001) retained a robust effect, with the estimate for LDL cholesterol (OR 0.85; 95% CI: 0.57-1.27; P = 0.44) reversing and that of triglycerides (OR 1.12; 95% CI: 1.02-1.23; P = 0.01) becoming weaker. Individual MR analyses showed a 1-standard-deviation-higher HDL cholesterol (OR 0.80; 95% CI: 0.75-0.86; P < 0.001) and apolipoprotein A-I (OR 0.83; 95% CI: 0.77-0.89; P < 0.001) to lower the risk of CHD, but these effect estimates attenuated substantially to the null on accounting for apolipoprotein B. A limitation is that, owing to the nature of lipoprotein metabolism, measures related to the composition of lipoprotein particles are highly correlated, creating a challenge in making exclusive interpretations on causation of individual components. CONCLUSIONS: These findings suggest that apolipoprotein B is the predominant trait that accounts for the aetiological relationship of lipoprotein lipids with risk of CHD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Hypertriglyceridemia is indirectly linked with changes in HDL-C and LDL-C composition that are conducive to accelerated atherogenesis.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [312]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Evidence from prospective longitudinal cohort studies and Mendelian randomization support a strong, dose-dependent relationship between LDL-C levels and ASCVD incidence [2, 3].”
From Targeting Triglycerides in Cardiovascular Disease Prevention: Evidence, Mechanisms, and Emerging Therapies (2026) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“From this perspective, triglycerides chiefly index TRL particle burden rather than act as an independent atherogen, and causal inferences often attenuate when apoB is accounted for in multivariable genetic analyses [2].”
From Targeting Triglycerides in Cardiovascular Disease Prevention: Evidence, Mechanisms, and Emerging Therapies (2026) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“At the same time, it is important to recognize that apoB remains the most informative single summary measure of atherogenic risk, as LDL apoB numerically dominates total apoB in most individuals; accordingly, the benefits of lipid-lowering therapy appear to correlate more closely with reductions in apoB (particle number) than with triglyceride lowering alone [2, 18, 19].”
From Targeting Triglycerides in Cardiovascular Disease Prevention: Evidence, Mechanisms, and Emerging Therapies (2026) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We also highlight that apoB is the most robust integrative metric of atherogenic particle exposure, with some trial benefits aligning more strongly with apoB reduction than with triglyceride lowering alone [2, 18].”
From Targeting Triglycerides in Cardiovascular Disease Prevention: Evidence, Mechanisms, and Emerging Therapies (2026) · cites this paper as [2]
Experimental — accuracy not yet measured
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Conducting Meta-Analyses in R with the metafor Package
Viechtbauer, W. (2010) · Journal of Statistical Software · doi:10.18637/jss.v036.i03 · Cited by 20,464
ggplot2: Elegant Graphics for Data Analysis
Wickham, H. (2009) · doi:10.1007/978-0-387-98141-3 · Cited by 14,447
ggplot2: Elegant Graphics for Data Analysis
Ginestet, C. (2011) · Journal of the Royal Statistical Society Series A: Statistics in Society · doi:10.1111/j.1467-985x.2010.00676_9.x · Cited by 13,726
Sudlow, C., Gallacher, J., Allen, N., Beral, V., Burton, P., Danesh, J., Downey, P., Elliott, P., Green, J., Landray, M., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001779 · Cited by 12,728
Second-generation PLINK: rising to the challenge of larger and richer datasets
Chang, C. C., Chow, C. C., Tellier, L. C., Vattikuti, S., Purcell, S. M., & Lee, J. J. (2015) · Gigascience · doi:10.1186/s13742-015-0047-8 · Cited by 12,709
Bowden, J., Davey Smith, G., & Burgess, S. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv080 · Cited by 9,816
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961
Self-citationBowden, J., Davey Smith, G., Haycock, P. C., & Burgess, S. (2016) · Genetic Epidemiology · doi:10.1002/gepi.21965 · Cited by 8,922 · cited 2×
“The repertoire of robust univariable MR approaches [51] that seek to act as sensitivity analyses for potential unbalanced horizontal pleiotropy each make a different series of assumptions [53].”
BackgroundMethodThe UK Biobank resource with deep phenotyping and genomic data
Bycroft, C., Freeman, C., Petkova, D., Band, G., Elliott, L. T., Sharp, K., Motyer, A., Vukcevic, D., Delaneau, O., O’Connell, J., et al. (2018) · Nature · doi:10.1038/s41586-018-0579-z · Cited by 8,876
The MR-Base platform supports systematic causal inference across the human phenome
Hemani, G., Zheng, J., Elsworth, B., Wade, K. H., Haberland, V., Baird, D., Laurin, C., Burgess, S., Bowden, J., Langdon, R., et al. (2018) · eLife · doi:10.7554/elife.34408 · Cited by 7,959
Research works printed but not linked: 1
- D Fry, 2019, Companion Document to Accompany Serum Biomarker Data, UK Biobank Biomarker Project
Cited by
Items 801–900 of 903
Miao, L., Miao, T., Zhang, Y., & Hao, J. (2024) · Figshare · doi:10.6084/m9.figshare.25853098
Miao, L., Miao, T., Zhang, Y., & Hao, J. (2024) · Figshare · doi:10.6084/m9.figshare.26722176
Leite, J. M. R. S., Pereira, J. L., Alves de Souza, C., Pavan Soler, J. M., Mingroni‐Netto, R. C., Fisberg, R. M., Rogero, M. M., & Sarti, F. M. (2024) · Figshare · doi:10.6084/m9.figshare.26754010
Leite, J. M. R. S., Pereira, J. L., Alves de Souza, C., Pavan Soler, J. M., Mingroni‐Netto, R. C., Fisberg, R. M., Rogero, M. M., & Sarti, F. M. (2024) · Figshare · doi:10.6084/m9.figshare.26753989
Leite, J. M. R. S., Pereira, J. L., Alves de Souza, C., Pavan Soler, J. M., Mingroni‐Netto, R. C., Fisberg, R. M., Rogero, M. M., & Sarti, F. M. (2024) · Figshare · doi:10.6084/m9.figshare.26753992
Topriceanu, C., Shah, M., Webber, M. R., Chan, F., Shiwani, H., Richards, M., Schott, J. M., Chaturvedi, N., Moon, J., Hughes, A. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26696055
Additional file 4 of The genetic etiology of body fluids on chronic obstructive airways disease
Cheng, Z. J., Wu, H., Chang, Z., Cheng, J., Wang, S., Liu, C., Zhang, Y., Xu, S., Wan, Q., Ron, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26669655
Kanoni, S., Graham, S. E., Wang, Y., Surakka, I., Ramdas, S., Zhu, X., Clarke, S. L., Bhatti, K. F., Vedantam, S., Winkler, T. W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22601243
Shui, X., Wen, Z., Dong, R., Chen, Z., Tang, L., Tang, W., Wu, Z., & Chen, L. (2023) · Figshare · doi:10.6084/m9.figshare.23916996
Additional file 6 of PCSK9 inhibitors and osteoporosis: mendelian randomization and meta-analysis
Chen, D.-Q., Xu, W.-B., Xiao, K.-Y., Que, Z.-Q., Jinyi, F., Sun, N.-K., Cai, D.-X., & Rui, G. (2024) · Figshare · doi:10.6084/m9.figshare.26749631
Kanoni, S., Graham, S. E., Wang, Y., Surakka, I., Ramdas, S., Zhu, X., Clarke, S. L., Bhatti, K. F., Vedantam, S., Winkler, T. W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22600985
Kanoni, S., Graham, S. E., Wang, Y., Surakka, I., Ramdas, S., Zhu, X., Clarke, S. L., Bhatti, K. F., Vedantam, S., Winkler, T. W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22601099
Leite, J. M. R. S., Pereira, J. L., Alves de Souza, C., Pavan Soler, J. M., Mingroni‐Netto, R. C., Fisberg, R. M., Rogero, M. M., & Sarti, F. M. (2024) · Figshare · doi:10.6084/m9.figshare.26754001
Chen, D.-Q., Xu, W.-B., Chen, X., Xiao, K.-Y., Que, Z.-Q., 孙乃坤, Jinyi, F., & Rui, G. (2024) · Figshare · doi:10.6084/m9.figshare.26639752
Miao, L., Miao, T., Zhang, Y., & Hao, J. (2024) · Figshare · doi:10.6084/m9.figshare.26722170
Chang, Z., Wang, S., Liu, K., Lin, R., Liu, C., Zhang, J., Wei, D., Nie, Y., Chen, Y., He, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26699291
Sandholm, N., Hotakainen, R., Haukka, J. K., Sigfrids, F. J., Dahlström, E. H., Antikainen, A. A., Valo, E., Syreeni, A., Kilpeläinen, E., Kytölä, A., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21622433
Kanoni, S., Graham, S. E., Wang, Y., Surakka, I., Ramdas, S., Zhu, X., Clarke, S. L., Bhatti, K. F., Vedantam, S., Winkler, T. W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22601135
Kanoni, S., Graham, S. E., Wang, Y., Surakka, I., Ramdas, S., Zhu, X., Clarke, S. L., Bhatti, K. F., Vedantam, S., Winkler, T. W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22601126
Chen, D.-Q., Xu, W.-B., Chen, X., Xiao, K.-Y., Que, Z.-Q., Sun, N.-K., Feng, J.-Y., & Rui, G. (2024) · Figshare · doi:10.6084/m9.figshare.26639764
Miao, L., Miao, T., Zhang, Y., & Hao, J. (2024) · Figshare · doi:10.6084/m9.figshare.25853194
Chen, D.-Q., Xu, W.-B., Chen, X., Xiao, K.-Y., Que, Z.-Q., Sun, N.-K., Jinyi, F., & Rui, G. (2024) · Figshare · doi:10.6084/m9.figshare.26639746
Schlosser, P., Zhang, J., Liu, H., Surapaneni, A. L., Rhee, E. P., Arking, D. E., Yu, B., Boerwinkle, E., Welling, P. A., Chatterjee, N., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23583594
Additional file 1 of PCSK9 inhibitors and osteoporosis: mendelian randomization and meta-analysis
Chen, D.-Q., Xu, W.-B., Xiao, K.-Y., Que, Z., Jinyi, F., Sun, N.-K., Cai, D.-X., & Rui, G. (2024) · Figshare · doi:10.6084/m9.figshare.26749616
Miao, L., Miao, T., Zhang, Y., & Hao, J. (2024) · Figshare · doi:10.6084/m9.figshare.26722164
Additional file 5 of PCSK9 inhibitors and osteoporosis: mendelian randomization and meta-analysis
Chen, D.-Q., Xu, W.-B., Xiao, K.-Y., Que, Z.-Q., Jinyi, F., Sun, N.-K., Cai, D.-X., & Rui, G. (2024) · Figshare · doi:10.6084/m9.figshare.26749628
Kanoni, S., Graham, S. E., Wang, Y., Surakka, I., Ramdas, S., Zhu, X., Clarke, S. L., Bhatti, K. F., Vedantam, S., Winkler, T. W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22601045
Additional file 2 of The genetic etiology of body fluids on chronic obstructive airways disease
Cheng, Z. J., Wu, H., Chang, Z., Cheng, J., Wang, S., Liu, C., Zhang, Y., Xu, S., Wan, Q., Ron, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25034506
Gong, Q., & Guo, C. (2023) · Figshare · doi:10.6084/m9.figshare.24797927
Leite, J. M. R. S., Pereira, J. L., Alves de Souza, C., Pavan Soler, J. M., Mingroni‐Netto, R. C., Fisberg, R. M., Rogero, M. M., & Sarti, F. M. (2024) · Figshare · doi:10.6084/m9.figshare.26753998
Teng, D., Jia, W., Wang, W., Liao, L., Xu, B., Gong, L., Dong, H., Zhong, L., & Yang, J. (2024) · Figshare · doi:10.6084/m9.figshare.25330865
Chen, D.-Q., Xu, W.-B., Chen, X., Xiao, K.-Y., Que, Z., 孙乃坤, Jinyi, F., & Rui, G. (2024) · Figshare · doi:10.6084/m9.figshare.26639767
Leite, J. M. R. S., Pereira, J. L., Alves de Souza, C., Pavan Soler, J. M., Mingroni‐Netto, R. C., Fisberg, R. M., Rogero, M. M., & Sarti, F. M. (2024) · Figshare · doi:10.6084/m9.figshare.26753995
Miao, L., Miao, T., Zhang, Y., & Hao, J. (2024) · Figshare · doi:10.6084/m9.figshare.26722179
Additional file 2 of Variants influencing age at diagnosis of HNF1A-MODY
Ludwig‐Słomczyńska, A. H., Seweryn, M. T., Radkowski, P., Kapusta, P., Machlowska, J., Pruhova, S., Gašperíková, D., Bellanné‐Chantelot, C., Hattersley, A. T., Kandasamy, B., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21117356
Leite, J. M. R. S., Pereira, J. L., Alves de Souza, C., Pavan Soler, J. M., Mingroni‐Netto, R. C., Fisberg, R. M., Rogero, M. M., & Sarti, F. M. (2024) · Figshare · doi:10.6084/m9.figshare.26754007
Si, J., Meir, A. Y., Hong, X., Wang, G., Huang, W., Pearson, C., Adams, W. G., Wang, X., & Liang, L. (2023) · Figshare · doi:10.6084/m9.figshare.24022843
Li, T., Deshan, Y., Wang, P., Jia, S., Zhang, C., Zhu, P., Song, Y., Tang, X., Zhao, X., Gao, Z., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21546685
Yang, G., & Schooling, C. M. (2024) · Figshare · doi:10.6084/m9.figshare.26560085
Huang, K., Huang, S., & Xiong, M. D. (2024) · Figshare · doi:10.6084/m9.figshare.25107880
Chang, Z., Wang, S., Liu, K., Lin, R., Liu, C., Zhang, J., Wei, D., Nie, Y., Chen, Y., He, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26699294
Su, C., Wan, S., Ding, J., 倪观太, & Ding, H. (2024) · Figshare · doi:10.6084/m9.figshare.25621904
Kou, H., Wang, H., Liu, P., Wang, X., Zhu, W., Jiang, W., Hu, X., & Deng, J. (2024) · Figshare · doi:10.6084/m9.figshare.25347238
Ba, H., Zhang, L., Peng, H., He, X., & Wang, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26687118
Xie, W., Li, J., Du, H., & Xia, J. (2023) · Figshare · doi:10.6084/m9.figshare.23949684
Ba, H., Zhang, L., Peng, H., He, X., & Wang, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26687121
Miao, L., Miao, T., Zhang, Y., & Hao, J. (2024) · Figshare · doi:10.6084/m9.figshare.26722182
Cao, Z., Li, Q., Li, Y., & Wu, J. (2024) · Figshare · doi:10.6084/m9.figshare.26631037
Schlosser, P., Zhang, J., Liu, H., Surapaneni, A. L., Rhee, E. P., Arking, D. E., Yu, B., Boerwinkle, E., Welling, P. A., Chatterjee, N., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23583597
Kou, H., Wang, H., Liu, P., Wang, X., Zhu, W., Jiang, W., Hu, X., & Deng, J. (2024) · Figshare · doi:10.6084/m9.figshare.26689184
Leite, J. M. R. S., Pereira, J. L., Alves de Souza, C., Pavan Soler, J. M., Mingroni‐Netto, R. C., Fisberg, R. M., Rogero, M. M., & Sarti, F. M. (2024) · Figshare · doi:10.6084/m9.figshare.26754004
Kanoni, S., Graham, S. E., Wang, Y., Surakka, I., Ramdas, S., Zhu, X., Clarke, S. L., Bhatti, K. F., Vedantam, S., Winkler, T. W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22601006
Additional file 4 of PCSK9 inhibitors and osteoporosis: mendelian randomization and meta-analysis
Chen, D.-Q., Xu, W.-B., Xiao, K.-Y., Que, Z., Jinyi, F., Sun, N.-K., Cai, D.-X., & Rui, G. (2024) · Figshare · doi:10.6084/m9.figshare.26749625
Kanoni, S., Graham, S. E., Wang, Y., Surakka, I., Ramdas, S., Zhu, X., Clarke, S. L., Bhatti, K. F., Vedantam, S., Winkler, T. W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22601078
Additional file 2 of PCSK9 inhibitors and osteoporosis: mendelian randomization and meta-analysis
Chen, D.-Q., Xu, W.-B., Xiao, K.-Y., Que, Z., Jinyi, F., Sun, N.-K., Cai, D.-X., & Rui, G. (2024) · Figshare · doi:10.6084/m9.figshare.26749619
Chen, D.-Q., Xu, W.-B., Chen, X., Xiao, K.-Y., Que, Z., Sun, N.-K., Jinyi, F., & Rui, G. (2024) · Figshare · doi:10.6084/m9.figshare.26639758
Chen, D.-Q., Xu, W.-B., Chen, X., Xiao, K.-Y., Que, Z., Sun, N.-K., Jinyi, F., & Rui, G. (2024) · Figshare · doi:10.6084/m9.figshare.26639761
Li, J., Yang, Z., Wang, T., Li, M., Wu, X., Fu, X., Yang, C., Li, Y., Wang, X., Lan, Z., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25951854
Cao, Z., Li, Q., Li, Y., & Wu, J. (2024) · Figshare · doi:10.6084/m9.figshare.26631040
Chang, Z., Wang, S., Liu, K., Lin, R., Liu, C., Zhang, J., Wei, D., Nie, Y., Chen, Y., He, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26699288
Zhang, S. K., Koyama, S., Bellomo, T. R., Haidermota, S., Hornsby, W., Honigberg, M. C., Ellinor, P. T., & Natarajan, P. (2025) · medRxiv · doi:10.64898/2025.12.11.25341921 · Cited by 1
Hu, W., Wu, Y., & Li, P. (2026) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-025-02191-w
Cholerton, B., Godrich, D., Pasteris, J., Rivero, J., Martin, E. R., Kunkle, B. W., Naj, A. C., Hamilton‐Nelson, K. L., Wang, H., Lee, W., et al. (2026) · medRxiv · doi:10.64898/2026.01.22.26344634
Wang, Y., Liu, X., & Huang, S. (2026) · Journal of International Medical Research · doi:10.1177/03000605261416738
Wang, W., Ye, J., Hu, X., Zongzheng, C., Wang, L., & Chen, L. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1767013 · Cited by 1
Tsao, N. L., Abramowitz, S. A., Shakt, G. E., Judy, R., Hilliard, A. T., Damrauer, S. M., Assimes, T. L., Clarke, S. L., Tcheandjieu, C., Levin, M. L., et al. (2026) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.125.005266 · Cited by 1
Lipoprotein(a) Augments Coronary Risk Estimation in Type 2 Diabetes: A Cross-sectional Study
Sharma, S., Chandak, R. K., Sharma, K. K., Guptha, S., & Gupta, R. K. (2026) · Journal of the Association of Physicians of India · doi:10.59556/japi.74.1331
Chen, S., Shen, H., Su, Y., Zhou, C., & Li, Y. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1699481
(Liver steatosis as a risk of coronary heart disease)
Poledne, R., Pajuelo, D., & Lesná, I. K. (2025) · Cor et Vasa · doi:10.33678/cor.2025.116
Wang, Y., & Huang, S. (2026) · Medicine · doi:10.1097/md.0000000000048021
Zheng, Q., Li, Y., Zhu, W., Ying, W., Xie, J., Yao, M., Sheng, G., & Li, L. (2026) · Microbial Pathogenesis · doi:10.1016/j.micpath.2026.108468
When the proteome meets the metabolome observational and Mendelian randomization analyses
Zheng, R., Delgado-Velandía, M., Ärnlöv, J., Sundström, J., Engström, G., Smith, J. G., Dekkers, K. F., Lundmark, P., Fall, T., & Lind, L. (2026) · Metabolism · doi:10.1016/j.metabol.2026.156602
Comprehensive mapping of human genetic variation at Epromoters
Wan, J. (2024) · theses.fr (ABES) · doi:10.70675/a2e4bbffze012z41baz8c31z2f84f271295e
Trujillo, J. M., Mohammadlou, A., Le, K., Feliciano, T. J., Rink, J. S., Roth, E. W., Dravid, V. P., Lu, K., Lavker, R. M., Peng, H., et al. (2026) · ACS Materials Au · doi:10.1021/acsmaterialsau.5c00241
Li, C., Zhai, Q., Wu, H., Du, C., Yuan, J., Peng, J., You, Y., Li, J., & Zhong, T. (2026) · Medicine · doi:10.1097/md.0000000000048439
A functional SNP rs12718466 in APOA1 promoter modulates gene expression via interaction with SOX7
Aita, Y., Takeuchi, Y., Masuda, Y., Saber, Z. M., Karkoutly, S., Tao, D., Ye, C., Mendsaikhan, T., Saikawa, R., Kondo, Y., et al. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113101
Chen, C., Sun, Z., Zhong, W., Zheng, H., Zuo, Z., Zhang, X., Wang, Y., Zhao, W., & Shen, B. T. (2026) · Medicine · doi:10.1097/md.0000000000048564
Beazer, J., Ljunggren, S., Karlsson, H., Davies, I. G., & Freeman, D. J. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1817349
Wang, J., Xin, Y., Li, B., Li, S., & Yang, G. (2026) · Genetics Research · doi:10.1155/genr/6618466
Childhood CV Risk Factors Predicting Adult CV Events
Woo, J. G. (2026) · Contemporary cardiology · doi:10.1007/978-3-032-14256-6_8
A 3′UTR polymorphism disrupts IRF2BP2 autoregulation through an eIF4H translational enhancer
Duong, A., Chen, H., & Stewart, A. F. R. (2026) · Frontiers in Genetics · doi:10.3389/fgene.2026.1846555
Polygenic Risk Links to the Gut Microbiome: The MAGI CatalogPreprint
Aasmets, O., Džigurski, J., Taba, N., Mändul, M., Laisk, T., Org, E., Mägi, R., & Läll, K. (2026) · medRxiv · doi:10.64898/2026.05.29.26354433
Ahn, J., Rhee, H., Chung, H. J., Hong, E., & Ryu, J. C. (2026) · CardioMetabolic Syndrome Journal · doi:10.51789/cmsj.2026.6.e21
Luo, J., Rasmussen, I. J., Thomassen, J. Q., & Frikke‐Schmidt, R. (2026) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2026.120824 · Cited by 1
Rethinking triglycerides in the management of atherosclerotic cardiovascular disease
Khanna, S., Bhatt, D. L., Libby, P., & Bhat, A. (2026) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwag341 · Cited by 1
Párraga-Viúdez, M. J., Sánchez-Gutiérrez, M., Quirós-Jiménez, A., Rangel-Zúñiga, O. A., López‐Miranda, J., Alcala-Diaz, J. F., & Delgado‐Lista, J. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.07.024
Interpreting Lower HDL Cholesterol in Plant-Based Diets: Mechanisms and Clinical Implications
Baker, K., & Vonderschmidt, A. (2026) · Advances in Nutrition · doi:10.1016/j.advnut.2026.100708
Wu, C., Sang, J., Xu, Q., Zhan, Y., Yuan, S.-J., Ge, Y.-Y., Yu, X.-J., Zheng, X., Wang, X.-F., He, X.-M., et al. (2026) · Functional & Integrative Genomics · doi:10.1007/s10142-026-01987-w
Björnson, E., & Adiels, M. (2026) · Current Atherosclerosis Reports · doi:10.1007/s11883-026-01442-y
Genedy, N., & Zouwail, S. (2026) · Journal of clinical lipidology · doi:10.1016/j.jacl.2026.07.022
DNA methylation informs adult cardiovascular risk and prevention for low birthweight individuals
Tang, J. Y., Ng, N. Y. T., Kwok, A. W. S., Mak, C. C. Y., Cheung, Y., & Chung, B. H. Y. (2026) · Journal of Global Health · doi:10.7189/jogh.16.04242
Chen, Y.-C., Liu, T.-Y., Liao, C., Yang, J., Lin, W., Liao, W., Chen, S., & Tsai, F. (2026) · Frontiers in Bioinformatics · doi:10.3389/fbinf.2026.1823599
Abdominal Adiposity and Lacunar Stroke: A Mendelian Randomization Mediation StudyPreprint
Guo, M., Cong, L., & Liu, Z. (2026) · medRxiv · doi:10.64898/2026.09.02.26362110
Yu, H., Zhang, X., Yang, S., Fan, Z., Zhang, D., & Dan, W. A. N. G. (2026) · Lipids · doi:10.1002/lipd.70085
Apolipoprotein B in cardiovascular risk assessment: beyond traditional lipid markers
Li, L., Feng, Y., Li, X., Yu, Z., Sun, C., Hu, L., Zhou, K., Liu, X., Yuan, Y., Li, L., et al. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1857230
Dragomir, T. L., Branea, H. S., Andor, M., Citu, I. M., Căruntu, F. R., Șușan, M. M., Oprean, C. M., Dragomir, R.-T., Șușan, R. M., Huțanu, D., et al. (2026) · Diagnostics · doi:10.3390/diagnostics16193245 · Cited by 1
Bedoya, C., Rejali, P., Mccleary, X., Hall, Z., Hoffmann, M. M., Green, L., Frost, P. H., Malloy, M. J., Pullinger, C. R., Kane, J. P., et al. (2026) · Journal of Lipid Research · doi:10.1016/j.jlr.2026.101168
Dietary Patterns and Chronic Disease Risk: A Proteomic Framework to Strengthen Causal Inference
van Dam, R. M., Lim, C. G. Y., & Cornelis, M. C. (2026) · Advances in Nutrition · doi:10.1016/j.advnut.2026.100755
Metadata
- Authors
- Richardson, T. G., Sanderson, E., Palmer, T. M., Ala-Korpela, M., Ference, B. A., Davey Smith, G., & Holmes, M. V.
- Affiliations
- University of Bristol (GB)
- University of Cambridge (GB)
- Corresponding author
- Richardson, Tom G.
- ORCID
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2020-03-23
- Volume
- 17
- Issue
- 3
- Pages
- e1003062
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC7089422
- OpenAlex
- W3012570809
- Cited by
- 843
- References
- 79
- Citations by year
- 2026: 68 · 2025: 132 · 2024: 206 · 2023: 190 · 2022: 124 · 2021: 91 · 2020: 30
- FWCI
- 67.37
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- medRxiv (acceptedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Lancaster EPrints (Lancaster University) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Bristol Research (University of Bristol) (submittedVersion, cc-by-nc-nd)
- Explore Bristol Research (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo (cc-by)
- Funders
- Medical Research Council (MC_UU_00011/1 and MC_UU-00011/2, MRC PHRU Oxford)
- UKRI (MR/S003886/1)
- National Health and Medical Research Council (APP1158958)
- Sigrid Juselius Foundation, Finland
- NIHR Cambridge Biomedical Research Centre
- British Heart Foundation (FS/18/23/33512)
- NIHR Oxford Biomedical Research Centre (Obesity theme)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- coronary artery disease, lipoprotein lipids, apolipoproteins, LDL cholesterol, triglycerides, HDL cholesterol, apolipoprotein B, apolipoprotein A-I, genetic instruments, causal inference, single nucleotide polymorphisms, genetic risk factors, UK Biobank
- MeSH terms
- Adult, Aged, Coronary Disease, Female, Humans, Cholesterol, HDL, Cholesterol, LDL, Male, Middle Aged, Phenotype, Risk Factors, Triglycerides, Biomarkers, Multivariate Analysis, Apolipoprotein A-I, Risk Assessment, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Apolipoprotein B-100, Genome-Wide Association Study, Mendelian Randomization Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.